Figure 1.
Figure 1. Flow cytometry analysis of iEMs incubated with patient (red) and plasmas from healthy donors (blue). (A) GαH IgG-Alexa 633 binding for iEMs incubated with APL versus healthy plasma; (B) A5 resistance with less A5-Alexa 647 binding iEMs incubated with APS plasma compared to healthy plasma.

Flow cytometry analysis of iEMs incubated with patient (red) and plasmas from healthy donors (blue). (A) GαH IgG-Alexa 633 binding for iEMs incubated with APL versus healthy plasma; (B) A5 resistance with less A5-Alexa 647 binding iEMs incubated with APS plasma compared to healthy plasma.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal